Nurse Practitioner, Family · Rochester, NY
NPI
1306073382
Since 2009
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
601 Elmwood Ave, Box Surg- Transplant
Rochester, NY, 14642
Phone (585) 275-5875
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,310
92 services
Medicare patients, 2024
43
Average age 64
Drug cost, 2024
$224K
928 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael Grizzanti was code 99215 (office e&m - established), 27 times for 23 patients. In total Michael Grizzanti billed 92 services in 7 codes, and Medicare paid $5,310.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-07-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 27 | 23 | $84.34 | $2,277 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 22 | 18 | $10.89 | $240 |
| 99215 Office E&M - Established | Office | 16 | 12 | $117.66 | $1,883 |
By year: 2022 $1,991 for 23 services; 2023 $4,837 for 64 services; 2024 $5,310 for 92 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael Grizzanti prescribed most often to Medicare patients was Tacrolimus, with 345 prescriptions and refills. In total Michael Grizzanti wrote 928 Medicare prescriptions that cost $224K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tacrolimus Generic | 345 | 627 | 89 | $43K |
| Mycophenolate Mofetil Generic | 106 | 192 | 30 | $8,833 |
| Ursodiol Generic | 104 | 245 | 34 | $19K |
| Prednisone Generic | 47 | 70 | 12 | $243 |
| Lamivudine Hbv Lamivudine | 40 | 91 | 11 | $7,945 |
| Envarsus Xr Tacrolimus | 29 | 46 | Under 11 | $14K |
| Gengraf Cyclosporine, Modified | 25 | 51 | Under 11 | $5,564 |
| Oxycodone Hcl Generic | 24 | 24 | Under 11 | $151 |
| Vemlidy Tenofovir Alafenamide | 23 | 23 | Under 11 | $29K |
| Sirolimus Generic | 23 | 45 | Under 11 | $21K |
| Entecavir Generic | 18 | 44 | Under 11 | $2,686 |
| Xifaxan Rifaximin | 16 | 16 | Under 11 | $49K |
| Tenofovir Disoproxil Fumarate Generic | 15 | 25 | Under 11 | $1,004 |
| Omeprazole Generic | 14 | 14 | Under 11 | $25.33 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 12 | 17 | Under 11 | $109 |
Brand drugs: - claims; generic drugs: 834 claims; opioid claims: 27.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Michael Grizzanti were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.